From scaffold to shield: how MCD1 organizes a phytoalexin metabolon for broad-spectrum plant immunity

Abstract Phytoalexins are low-molecular-weight antimicrobials that plants synthesize de novo upon pathogen attack, forming a frontline chemical defense arsenal. Despite decades of study, the genetic basis and regulatory mechanisms governing their biosynthesis have remained surprisingly fragmentary. A landmark study by Wang et al. (Cell, 2026, https://doi.org/10.1016/j.cell.2026.04.021 ) closes this gap for the fungicidal sesquiterpenoid debneyol by elucidating its complete three-enzyme dominated biosynthesis pathway (EAS–EAE–EH1) from farnesyl pyrophosphate, identifying the Solanaceae-specific miR1919–MCD1 module as a regulatory switch, and revealing that MCD1 functions as a metabolic organizer—a scaffold protein that enhances EAS–EAE association and EAE catalytic efficiency while competitively directing substrate flux away from the capsidiol branch toward debneyol synthesis. This metabolic channeling mechanism contributes to rapid, broad-spectrum disease resistance against fungal, viral, and bacterial pathogens. Inducible expression of MCD1 under the TBF1::uORFs promoter achieves disease resistance while minimizing the fitness costs associated with constitutive defense activation (Xu et al. 2017). This work uncovers a genetic framework for phytoalexin-mediated chemical defense, reveals metabolic organizers as a new class of immune regulators, and offers a novel strategy for engineering disease-resistant crops and microbial production of bioactive phytoalexins.